Trials / Completed
CompletedNCT02146820
Picosecond Laser for Ttreatment of Benign Pigmented Lesions
LASER TREATMENT OF BENIGN PIGMENTED LESIONS WITH A DUAL WAVELENGTH PICOSECOND LASER
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (actual)
- Sponsor
- Syneron Medical · Industry
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine whether Pico laser is effective and safe in the treatment of benign pigmented lesions.
Detailed description
The Investigational device is a dual wavelength laser system developed for treatment of pigmented lesions and for tattoo removal. The base unit is a GentleMax system modified to emit light at wavelengths of 532 and 1064 nm and deliver pulse energy up to 400mJ, and pulse duration of 700 ps.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | GentleMax system | Picosecond Laser System for the Treatment of Pigmented Lesions |
Timeline
- Start date
- 2013-12-01
- Primary completion
- 2015-05-01
- First posted
- 2014-05-26
- Last updated
- 2015-06-26
Locations
2 sites across 2 countries: United States, China
Source: ClinicalTrials.gov record NCT02146820. Inclusion in this directory is not an endorsement.